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ABSTRACT
Introduction: Sustained deep neuromuscular
blockade (NMB) during laparoscopic surgery
may facilitate optimal surgical conditions. This
exploratory study assessed whether deep NMB
improves surgical conditions and, in doing so,
allows use of lower insufflation pressures during
laparoscopic cholecystectomy. We further
assessed whether use of low insufflation pres-
sure improves patient pain scores after surgery.
Methods: This randomized, controlled, blinded
study (NCT01728584) compared use of deep
(1–2 post-tetanic-counts) or moderate (trai-
n-of-four ratio 10%) NMB, and lower (8 mmHg)
or higher (12 mmHg; ‘standard’) insufflation
pressure in a 2 9 2 factorial design. Primary
endpoint was surgeon’s overall satisfaction with
surgical conditions, rated at end of surgery
using an 11-point numerical scale. Post-opera-
tive pain scores were also evaluated. Data were
analyzed using analysis of covariance.
Results: Of 127 randomized patients, 120 had
evaluable data for the primary endpoint. Sur-
geon’s score of overall satisfaction with surgical
conditions was significantly higher with deep
versus moderate NMB indicated by a least-
square mean difference of 1.1 points (95%
confidence interval 0.1–2.0; P = 0.026). Fur-
thermore, strong evidence of an effect was
observed for standard versus low pressure:
least-square mean difference of 3.0 points (95%
confidence interval 2.1–4.0; P\0.001). No sig-
nificant difference was observed in average pain
scores within 24 h post-surgery for low versus
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standard pressure [0.17 (95% confidence inter-
val -0.67 to ?0.33); P = 0.494].
Conclusions: Although associated with signifi-
cantly improved surgical conditions, deep NMB
alone was insufficient to promote use of low
insufflation pressure during laparoscopic
cholecystectomy. Furthermore, low insufflation
pressure did not result in reduced pain, com-
pared with standard pressure.
Clinical Trial Registration: ClinicalTrials.gov
identifier, NCT01728584.
Funding: Merck Sharp and Dohme Corp., a
subsidiary of Merck & Co., Inc., Kenilworth, NJ,
USA.
Keywords: Deep neuromuscular blockade;
Insufflation pressure; Laparoscopy; Pain;
Surgical conditions
INTRODUCTION
Laparoscopic procedures are becoming increas-
ingly frequent in clinical practice due to a
number of benefits versus open surgery,
including faster recovery, shorter hospitaliza-
tion times, less post-operative pain, and an
improved cosmetic result [1]. Creating a pneu-
moperitoneum with insufflation of CO2 at
approximately 12–15 mmHg is routine in
laparoscopic procedures [2] to provide an
acceptable view of the surgical field. However,
the raising of intra-abdominal pressure results
in a variety of physiological changes [3], and
has been associated with pain [4]. Previous
studies have found use of lower CO2 insuffla-
tion pressures to be advantageous in terms of
pain levels experienced post-operatively [4–6],
although these findings have not been consis-
tent across other studies [7].
Neuromuscular blocking agents (NMBAs) are
used adjunctively to anesthesia to facilitate tra-
cheal intubation, relax the abdominal muscles
and reduce patient movements during surgery.
Use of deeper levels of neuromuscular blockade
(NMB) can improve surgical conditions in
laparoscopic procedures [8], with potential ben-
efits of sustained NMB throughout the whole
procedure including an enhanced visual field, as
well as increased ease of surgical access and
manipulation and facilitation of closure. A limi-
tation of the use of deep NMB in the past was the
lack of reversal agent that would allow the anes-
thesiologist to reliably, predictably and rapidly
reverse a deep NMB at any given time during
surgery. However, sugammadex has now been
approved in more than 80 countries as a novel
compound proven to reverse deep levels of NMB
rapidly and safely.
The relationship between insufflation pres-
sure and depth of NMB has not been systemat-
ically studied. Therefore, the present study was
intended as a first step to investigate the
potential of a combination of deep NMB with a
lower level of insufflation pressure to provide a
potential two-fold benefit in the setting of
endoscopic abdominal surgery: optimal surgical
conditions for the surgeon and reduced
post-operative pain for the patient. The primary
objective of the study was to assess the benefit
of deep NMB on surgical conditions when
compared with moderate NMB, assessed in the
context of low and standard insufflation pres-
sure during laparoscopic cholecystectomy. A
secondary objective was to assess whether the
use of low insufflation pressure improves the
patient’s overall pain score within 24 h after
surgery.
METHODS
Study Design and Patients
This was a randomized, controlled, paral-
lel-group, blinded study (Clinicaltrials.gov
identifier NCT01728584; Sponsor Protocol
Number P076), conducted at eleven centers
(two in Austria, two in Finland, five in Ger-
many, one in Italy and one in the United
Kingdom) from January 2013 to April 2014. The
study was conducted in accordance with prin-
ciples of Good Clinical Practice and with the
Helsinki Declaration of 1964, as revised in 2013,
and was approved by the appropriate institu-
tional review board/ethics committees.
Informed consent was obtained from all
patients for being included in the study. The
study is reported according to the CONSORT
statement.
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Included patients were adults of American
Society of Anesthesiologists Class 1–3, with
body mass index (BMI)\35 kg/m2, scheduled to
undergo laparoscopic cholecystectomy under
general anesthesia and rocuronium-induced
NMB. All patients were required to provide
written, informed consent. Patients were
excluded if they had suspected difficult intuba-
tion, a history of previous abdominal surgery, a
history of substance abuse or dependence, evi-
dence of acute cholecystitis, renal or liver dys-
function, a history of a chronic pain condition,
known intolerance to any drug used or planned
to use for anesthesia, or if they had participated
in any other clinical trial within 30 days. Female
patients were also excluded if they were preg-
nant or were planning to become pregnant
within the study period or had given birth to
one or more children within the last year.
The study examined two depths of blockade
and two insufflation pressures in a 2 9 2 facto-
rial design: moderate blockade [train-of-four
(TOF) ratio of 10%; range TOF count 2–3 to TOF
ratio of 20%], deep blockade [1–2 post-tetanic
counts (PTC); range 1–5 PTC], standard pressure
(set as 12 mmHg), and low pressure (8 mmHg).
This design allows for inferential statistical
analysis of the effect of depth of blockade as
well as insufflation pressure.
Using an interactive voice response system,
patients were randomized centrally in a 1:1:1:1
ratio to one of each of the four combinations
(Fig. 1) stratified by the surgeon/surgical team
(i.e., surgeon with anesthesiologist) at the site
Fig. 1 Patient ﬂow-through study; NMB neuromuscular blockade. aSurgeons were allowed to change surgical conditions as
needed; therefore, a patient’s ﬁnal treatment may be different from their randomized assignment
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level. Any patients that prematurely discontin-
ued from the study and had missing outcome
for the primary/key secondary endpoint(s) were
replaced by a patient assigned to the same sur-
geon with the same treatment assignment.
Study Procedures
Anesthesia and NMB Regimen
All patients received a standard regimen for
general anesthesia using total intravenous
anesthesia. Propofol (2.5 mg/kg) and remifen-
tanil (1 lg/kg) were given for anesthesia induc-
tion. Anesthesia was maintained with a
propofol infusion, titrated to maintain a bis-
pectral index of 40–50 throughout surgery with
a starting infusion rate of 6–12 mg/kg/h
(100–200 lg/kg/min). Remifentanil infusion
was adapted (0.25 lg/kg/min) as required by the
anesthesiologist based on the hemodynamic
reactions. An intravenous bolus dose of
0.45 mg/kg rocuronium was given for intuba-
tion, with additional bolus doses or rocuronium
infusion used to maintain NMB at the required
depth. NMB was monitored using the TOF-
Watch SX (Organon Ireland, a subsidiary of
Merck, Swords, Co. Dublin, Ireland). Moderate
NMB was maintained at a targeted TOF ratio of
10% (range TOF count of 2–3 to a TOF ratio of
20%). Deep NMB was maintained at a targeted
depth of 1–2 PTC (range 1–5 PTC).
Once the target depth of NMB was reached,
CO2 insufflation was initiated. The pneu-
moperitoneum was continuously controlled by
the anesthesiologist, with the surgical team
blinded to the applied insufflation pressure. If
surgical conditions were deemed unaccept-
able with the assigned treatment, rescue inter-
ventions could be performed. For patients
randomized to moderate NMB, the depth of
NMB could be increased to 1–2 PTCs. Further,
the pneumoperitoneum pressure could be
increased by 4 mmHg. For patients already
under deep NMB, pneumoperitoneum pressure
could be increased by 4 mmHg.
The surgical conditions assessment score was
obtained from the surgeon shortly after surgery.
Patients who underwent rescue intervention
were assigned the worst possible surgical con-
ditions assessment score of 0.
After the last dose of rocuronium, a single
intravenous bolus dose of sugammadex 2 or
4 mg/kg was administered within 10 s into a
fast-running intravenous infusion for reversal of
moderate and deep NMB, respectively.
Pain Management Regimen
At the end of the remifentanil infusion and
prior to extubation, a bolus dose of 8 mg mor-
phine was administered. Patients received
morphine via patient-controlled analgesia for
2 h while in the post-anesthesia care unit
(PACU). After discharge from the PACU,
patients were provided with oral pain medica-
tion of 4 9 400 mg ibuprofen and 4 9 1000 mg
paracetamol until day 5. Additional pain medi-
cation could be taken as needed by the patient,
with use of all pain medications systematically
recorded until day 8.
Blinding
The patient, surgeon, and safety assessors were
all blinded to treatment. The anesthesiologists
were not blinded as they needed to control the
depth of NMB and record the dose and time of
administration of all medications, insufflation
pressures, and changes to the insufflation pres-
sure or NMB as requested by the surgeon. The
surgeon was also blinded to the type of rescue
intervention.
Assessments
Surgeons rated several parameters of surgical
conditions at end of surgery (primary endpoint)
using an 11-point (discrete) numerical scale
from 0 (poor, needs intervention) to 10 (excel-
lent). The pre-specified primary endpoint in this
study was the surgeon-rated overall satisfaction
at end of surgery. Additional secondary end-
points included specific aspects of the surgical
conditions, surgeon’s satisfaction with surgical
field visibility, surgeon’s overall rating of ade-
quacy of muscle relaxation and insufflation
pressure, the number of patient movements
interfering with surgical conditions, and the
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number of rescue actions performed during
surgery to improve surgical conditions.
After completion of surgery, patients recor-
ded their pain intensity at rest and when pro-
voked by transition from lying to sitting
position, and post-operative shoulder pain at
the time of the assessment, using a numerical
scale from 0 (no pain) to 10 (severe pain).
Patients rated their pain score at 1, 2, 4, 24 and
48 h, post-operatively as well as daily in the
morning on days 3–8. The key secondary end-
point was the pain score within 24 h (average of
the pain assessments at 1, 2, 4 and 24 h). The
amount of pain medication received post-oper-
atively was assessed as an exploratory endpoint.
Safety was assessed via monitoring of adverse
events (AEs) and vital signs. Incidences of nau-
sea and vomiting were recorded, as were anal-
gesic and anti-emetic medication consumption,
until day 8. Clinical evidence of residual NMB
or recurrence of NMB (e.g., significant change
in respiratory rate or oxygen saturation level)
was assessed from time of reversal of NMB with
sugammadex until the patient was ready for
discharge from the PACU.
Statistical Analysis
The primary hypothesis was that use of sus-
tained deep NMB improves the surgeon’s over-
all satisfaction with surgical conditions,
compared with moderate NMB. The key sec-
ondary hypothesis was that use of low insuffla-
tion pressure improves the patient overall pain
score within 24 h.
A sample size of 30 patients per each of the
four treatment groups was determined to have a
power of more than 80% to analyze the primary
hypothesis at an overall two-sided 5% alpha-
level, if the underlying treatment difference in
the mean surgical conditions score was at least
52% of the standard deviation [9]. The sample
size was also determined to provide 80% power
to analyze the key secondary hypothesis.
The efficacy analyses were performed on the
full analysis set (FAS), defined as all randomized
patients who received rocuronium-induced
NMB and pneumoperitoneum, according to
randomization, and who did not convert to
open surgery before the start of application of
NMB and/or insufflation pressure. Analysis of
covariance (ANCOVA) was performed, using
factors for depth of NMB, level of insufflation
pressure, surgeon; with BMI added for the pri-
mary efficacy analysis and gender added for the
key secondary analysis. ANCOVA was per-
formed using SAS 9.1 (SAS Institute, Cary, NC,
USA). A hierarchical approach was taken to
control for multiple testing: the primary con-
trast for the primary endpoint was tested at a
level of 5%. Only if the associated null
hypothesis could be rejected at that level, the
contrast of interest for the key secondary end-
point was tested at a level of 5%. A rescue
change in the level of insufflation pressure and/
or depth of NMB due to unacceptable surgical
conditions was permitted per the protocol.
According to the pre-defined analysis plan, the
score for any patients for whom rescue was
required was to be imputed as the worst possible
assessment score of 0.
The interaction between the two treatment
factors (depth of NMB and insufflation pressure)
was investigated in a sensitivity analysis, by
adding an interaction term to the ANCOVA
model. In the case of deviation from normality,
a stratified Wilcoxon (non-parametric) test was
also performed as a supportive analysis. This
analysis compared the two levels of one treat-
ment factor [providing Hodges–Lehmann esti-
mates for the median difference and associated
95% confidence interval (CI)] while using the
two levels of the other treatment factor as strata.
For the primary parameter, the main compar-
ison was deep NMB versus standard NMB, and
for the key secondary parameter (average pain
score), low pressure versus standard pressure.
The sensitivity analyses were interpreted in an
exploratory sense, with unadjusted P val-
ues\0.05 considered nominally significant.
All safety analyses were performed on the
all-patients-as-treated (APaT) set, defined as all
randomized patients who received rocuro-
nium-induced NMB or pneumoperitoneum,
according to actual treatment conditions (depth
of NMB and level of insufflation pressure).
Amount of pain medication received
post-operatively was analyzed via ANCOVA.
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RESULTS
Of 127 randomized patients, 122 received
treatment with rocuronium and pneumoperi-
toneum according to randomization, and were
included in the FAS population for efficacy
analyses. Two patients discontinued prema-
turely and were not evaluable; therefore 120
had evaluable data for the primary endpoint
(Fig. 1). There was a greater proportion of male
(62.2%) versus female (37.8%) patients. Patient
characteristics are shown in Table 1.
In total, 122 patients were included in the
APaT population for safety analyses; 12 patients
(moderate blockade/low pressure, n = 7; deep
blockade/low pressure, n = 5) had a permitted
rescue change in level of insufflation pressure
and/or depth of NMB after start of surgery due
to unacceptable surgical conditions. No patient
in the standard pressure groups required rescue
intervention.
Efficacy
The surgeon’s score of overall satisfaction with
surgical conditions was significantly better with
deep versus moderate NMB by 1.1 points on the
10-point scale (95% CI 0.1–2.0; P = 0.026)
(Table 3; Fig. 2). Improvement in surgical con-
ditions was also observed with standard versus
low pressure by 3.0 points (95% CI 2.1–4.0;
unadjusted P\0.001; Fig. 2). This analysis was
not associated with a pre-specified hypothesis,
but was performed for completeness of the
assessment of the effect of both factors in the
factorial design. The breakdown of surgical
scores and ANCOVA results for the combined
NMB and pressure groups are shown in Table 2.
The pre-specified sensitivity analysis of the
primary endpoint, using the actual assessment
score for surgical conditions before any rescue
intervention, supported the results of the pri-
mary approach (Table 3). Additionally, a
Table 1 Patient baseline characteristics (all-patients-as-randomized set)
n (%) Moderate
NMB 1 moderate
pressure (n5 36)
Moderate
NMB 1 low
pressure (n5 30)
Deep
NMB 1 moderate
pressure (n5 31)
Deep
NMB 1 low
pressure (n5 30)
Total
(n5 127)
Gender
Male 21 (58.3) 19 (63.3) 18 (58.1) 21 (70.0) 79 (62.2)
Female 15 (41.7) 11 (36.7) 13 (41.9) 9 (30.0) 48 (37.8)
Age, years
\65 28 (77.8) 29 (96.7) 29 (93.5) 26 (86.7) 112 (88.2)
C65 8 (22.2) 1 (3.3) 2 (6.5) 4 (13.3) 15 (11.8)
Mean (SD) 46.1 (17.7) 39.1 (13.6) 43.5 (15.6) 46.7 (13.8) 43.9 (15.5)
ASA Class
1 15 (41.7) 16 (53.3) 17 (54.8) 17 (56.7) 65 (51.2)
2 13 (36.1) 13 (43.3) 10 (32.3) 11 (36.7) 47 (37.0)
3 2 (5.6) 1 (3.3) 3 (9.7) 2 (6.7) 8 (6.3)
Unknown 6 (16.7) 0 (0.0) 1 (3.2) 0 (0.0) 7 (5.5)
BMI, kg/m
Subjects with data, n 34 30 31 30 125
Mean (SD) 25.9 (2.9) 27.5 (4.0) 27.1 (3.7) 28.7 (2.7) 27.2 (3.4)
ASA American Society of Anesthesiologists, BMI body mass index, NMB neuromuscular blockade
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pre-specified non-parametric analysis was per-
formed due to evidence that the residuals of the
ANCOVA model of the primary endpoint were
non-normally distributed with non-homoge-
neous variance. This supportive analysis resul-
ted in a P value of 0.321 for deep versus
moderate NMB and P\0.001 for low versus
standard pressure. Surgical conditions assess-
ments are shown in Table 3.
Another sensitivity analysis, adjusting for
the estimated interaction between depth of
NMB and insufflation pressure, showed nearly
identical results as the primary approach for
deep versus moderate NMB by 1.07 points
(0.12–2.02); P = 0.028. Results of this analysis
thus supported the primary result demonstrat-
ing the effect of deep versus moderate NMB.
The difference in overall average pain score
in the first 24 h after surgery was not statistically
significant for either low versus standard pres-
sure or for deep versus moderate NMB (Fig. 3).
No significant differences in shoulder pain were
observed between the groups. Results for the
key secondary analysis were supported by
results of the sensitivity analyses by 0.3 points
(95% CI -0.2 to ?0.8; P = 0.223) for deep versus
moderate NMB and 0.2 points (95% CI -0.4 to
?0.7; P = 0.565) for standard versus low pres-
sure. There was no significant departure from
normality or homogeneity of variance for the
residuals of the ANCOVA model for the pain
scores.
Safety
There were similar incidences of AEs between
the four treatment groups. The majority of the
AEs were of mild severity, and none were con-
sidered drug-related. The most frequently
recorded AE was pain (88%), followed by nausea
(21%), vomiting (13%), pyrexia (13%), and
wound hemorrhage (9%) (Supplementary
Table 1). Six serious AEs were reported for four
patients: procedural pain and procedural hem-
orrhage in one subject each, wound hemor-
rhage and hematoma in one subject, and
necrotizing fasciitis and sepsis in one subject.
None were considered related to study
medication.
DISCUSSION
This study confirmed the primary hypothesis
that use of deep NMB has an advantage over
moderate NMB in improving surgeon satisfac-
tion with surgical conditions in laparoscopic
cholecystectomy. A greater degree of muscle
relaxation afforded by deep levels of NMB pro-
vides improved visibility for the surgeon and
fewer involuntary patient movements [9].
In the current study, maintenance of deep
NMB throughout surgery was not shown to
allow use of lower insufflation pressures with-
out compromising acceptable surgical condi-
tions. Higher levels of intra-abdominal pressure
provide increased elevation of the anterior
abdominal wall and thus more space for surgical
dissection and an enhanced visual field [4].
While not a pre-specified comparison, the
results also suggest the possibility of a larger role
for insufflation pressure on surgical conditions
compared with that of depth of blockade. For
instance, no patient in the standard pressure
groups required rescue intervention in the pre-
sent study, whereas a total of 12 patients in the
Fig. 2 Surgeon’s assessment of overall satisfaction with
surgical conditions during surgery (estimates from
ANCOVA; full analysis set)a. D difference, LSM least-
squares means, NMB neuromuscular blockade. aStatisti-
cally signiﬁcant (P\0.05). bNominally signiﬁcant (ex-
ploratory objective, unadjusted P\0.05)
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low pressure groups (7 in the moderate NMB
group and 5 in the deep NMB group) underwent
rescue intervention via increase in insufflation
pressure and/or level of NMB due to surgical
conditions which were deemed unacceptable by
the surgeon.
Use of deep NMB and low pressure resulted
in an improvement in surgical conditions
compared with use of moderate NMB with low
pressure (the group with the worst surgical
conditions), with 1.7 points (95% CI 3.0–0.4)
(Table 2). In contrast, use of deep NMB and
standard pressure resulted in an improvement
in surgical conditions compared with use of
moderate NMB with low pressure of 4.1 points
(95% CI 5.4–2.8) (Table 2). Use of deep NMB
with low pressure was found to provide less
benefit on conditions than moderate NMB with
Table 2 Surgeon’s assessment of overall satisfaction with surgical conditions (full analysis set)
n (%) Moderate
NMB 1 moderate
pressure
(n5 31)
Moderate
NMB 1 low
pressure
(n5 30)
Deep
NMB 1 moderate
pressure (n5 31)
Deep
NMB 1 low
pressure (n5 30)
Scorea
0 0 (0.0) 8 (26.7) 0 (0.0) 5 (16.7)
2 0 (0.0) 2 (6.7) 0 (0.0) 0 (0.0)
3 1 (3.3) 1 (3.3) 0 (0.0) 0 (0.0)
4 0 (0.0) 2 (6.7) 0 (0.0) 1 (3.3)
5 0 (0.0) 0 (0.0) 0 (0.0) 3 (10.0)
6 1 (3.3) 2 (6.7) 2 (6.7) 1 (3.3)
7 1 (3.3) 4 (13.3) 1 (3.3) 2 (6.7)
8 5 (16.7) 3 (10.0) 5 (16.7) 6 (20.0)
9 5 (16.7) 2 (6.7) 6 (20.0) 4 (13.3)
10 17 (56.7) 6 (20.0) 16 (53.3) 8 (26.7)
Missingb 1 0 1 0
Mean (SD) 9.03 (1.56) 5.23 (3.94) 9.10 (1.21) 6.77 (3.52)
LSM (95% CI) 8.65 (7.58, 9.72) 4.99 (3.88, 6.11) 9.09 (8.02, 10.17) 6.69 (5.57, 7.80)
Estimated difference Difference in LSM (95% CI)
Moderate NMB ? moderate pressure vs moderate NMB ? low pressure 3.66 (2.30–5.02)
Moderate NMB ? moderate pressure vs deep NMB ? moderate pressure –0.44 (–1.80 to ?0.91)
Moderate NMB ? moderate pressure vs deep NMB ? low pressure 1.96 (0.57–3.36)
Moderate NMB ? low pressure vs deep NMB ? moderate pressure –4.10 (–5.42 to –2.78)
Moderate NMB ? low pressure vs deep NMB ? low pressure –1.70 (–3.01 to –0.38)
Deep NMB ? moderate pressure vs deep NMB ? low pressure 2.41 (1.08–3.74)
LSM least-squares mean, NMB neuromuscular blockade
a A score of 0 was used for patients with a rescue change in level of NMB or pressure
b Not included in summary statistics for score
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standard pressure with 2.0 points (95% CI
0.5–3.4) (Table 2). Therefore, the results from
the present study indicate that deep NMB does
not replace the need for use of appropriate
insufflation pressure with respect to surgical
conditions.
The incidence of shoulder tip pain following
laparoscopic cholecystectomy is approximately
30–50% in the literature [10, 11]. Prior to the
design of this study, a Cochrane review [5]
concluded that low insufflation pressures were
associated with lower post-operative pain
scores. This in part formed the hypothesis of the
current study that low insufflation pressure
combined with deep NMB would result in a
lower incidence of patient post-operative pain.
However, no significant differences in shoulder
pain were observed between the groups in the
present study.
The etiology of post-operative pain is com-
plex, although diaphragmatic irritation is gen-
erally considered the likely causative factor of
post-operative shoulder tip pain, whether by
conversion of CO2 to carbonic acid [12] or
overstretching of the diaphragmatic muscle
fibers [13]. However, stretched pain receptors in
the peritoneum can occur both due to high
rates of insufflation and as a result of the sur-
gical procedure itself. In addition, the stan-
dardized post-operative pain regimen
established for this protocol may have masked
possible differences in post-operative pain levels
between the two groups, contributing to the
lack of observed effect.
Of note, during the conduct of the present
study, the Cochrane report was revised,
Table 3 Surgeon’s surgical conditions assessments (full analysis set)
Assessment score after surgery Pairwise comparison
Moderate NMB Deep NMB Deep versus moderate NMB
n LSM n LSM (95% CI)a Difference in LSM (95% CI) P value
Surgical conditions 60 6.8 60 7.9 1.1 (0.1–2.0) 0.026
Visual ﬁeld 60 6.9 60 7.8 0.9 (–0.1 to –1.9) 0.063
Muscle relaxation adequacy 60 8.1 60 8.9 0.8 (0.3–1.4) 0.004
Insufﬂation pressure adequacy 60 6.7 60 7.9 1.1 (0.3–1.9) 0.006
Number of movements interfering 60 0.9 59 0.3 –0.6 (–1.3 to ?0.1) 0.073
Disruption of surgical performance 60 9.2 60 9.9 0.7 (0.2–1.3) 0.009
LSM least-squares mean, NMB neuromuscular blockade
a Based on an analysis of covariance model with factors for depth of NMB (two levels: deep, moderate), level of pressure
(two levels: low, standard), body mass index and surgeon
Fig. 3 Average pain score in the ﬁrst 24 h after sugam-
madex administration (estimates from ANCOVA; all-pa-
tients-as-treated set). LSM least-squares means, NMB
neuromuscular blockade
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suggesting insufficient evidence for lower pain
levels using low pressure pneumoperitoneum,
which is in line with our findings in this study
[6]. Therefore, it remains a challenge to inves-
tigate pain protection while still maintaining
adequate surgical conditions.
This was a pilot study which aimed to
investigate the potential for a two-fold benefit
for surgeons and patients via use of a combi-
nation of deep NMB and low insufflation pres-
sure for endoscopic surgery. Laparoscopic
cholecystectomy was chosen for this explora-
tory study as it is a frequently performed pro-
cedure; however, it cannot be ruled out that the
greater effects observed with insufflation pres-
sure compared with NMB are at least in part due
to the insufflation pressures chosen for investi-
gation. Retrospectively, 8 mmHg may have
been too low a pressure to use in a standard
surgical population and assessment of a greater
range of insufflation pressures may be needed to
confirm the benefit of deep neuromuscular
block for surgical conditions.
CONCLUSION
This study demonstrated that the use of sus-
tained deep NMB improves surgical conditions
when a low insufflation pressure was applied.
However, deep NMB alone cannot adequately
replace standard insufflation pressure with
respect to surgical conditions. Further studies
utilizing a greater range of insufflation pressures
may be warranted to ascertain any potential
benefits of a lower pressure with respect to sur-
gical conditions. The level of insufflation pres-
sure did not influence the average pain scores
measured during 24 h post-surgery.
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